On Friday, Shares of SunTrust Banks, Inc. (NYSE:STI), added 1.51% and closed at $43.80 in the last trading session. The last trading range of the stock ranges between $43.13 and $44.09. This week 125 years ago, the Georgia State Legislature approved the incorporation of the Commercial Travelers’ Savings Bank, the earliest Georgia forerunner to what is now SunTrust Banks, Inc. (STI).
Founded by 24 people from all walks of life with various business backgrounds, the institution became known as Trust Company of Georgia in 1893 and changed its focus from a savings and loan institution to managing trusts and engaging in investment banking and underwriting securities.
In 1985, Trust Company of Georgia merged with SunBanks, Inc. of Florida to form SunTrust Banks, Inc., representing the Southeast’s first regional interstate bank merger. The company’s headquarters was established, and continues to be, in Atlanta.
Recently, SunTrust Banks, Inc. is now a top ten U.S. bank employing nearly 24,000 people and operating three business segments: Consumer and Private Wealth Administration, Wholesale Banking and Mortgage. Its retail branches are concentrated in the Southeast and Mid-Atlantic states, with other business operating nationally.
Throughout the years, SunTrust’s history has been woven into Atlanta’s – from the high-rise buildings and growth of businesses into international entities, to the organizations that serve the most basic needs of the community.
Novartis AG (ADR)(NYSE:NVS), dropped -0.37% and closed at $78.96 in the last trading session. The last trading range of the stock ranges between $78.28 and $79.14. The company’s Market capitalization is $207.02 Billion with the total Outstanding Shares of 2.38 billion. Novartis declared recently that the US Food and Drug Administration (FDA) has granted three simultaneous approvals for the expanded use of Ilaris® (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.
Ilaris is the first and only FDA-approved biologic treatment for patients with Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS), Hyperimmunoglobulin D Syndrome (HIDS)/Mevalonate Kinase Deficiency (MKD) and Familial Mediterranean Fever (FMF).1,2 All three conditions are part of a group of rare autoinflammatory diseases called Periodic Fever Syndromes, which are also referred to as Hereditary Periodic Fevers (HPF). The most common syndrome is FMF, which mainly affects people of Eastern Mediterranean ancestry. It affects 1 in 250 to 1 in 1,000 individuals in these populations, many of whom are children.3
“We are grateful to the scientists, clinical trial investigators and all associates who worked tirelessly in support of patients to gain three simultaneous FDA approvals of ILARIS,” said Fabrice Chouraqui, President of Novartis Pharmaceuticals Corporation, “It is through their hard work that Novartis can offer a desperately needed new treatment option to the adults and children who suffer from these debilitating conditions and continue to serve the rare disease community.”
The FDA approvals are based on results from the pivotal Phase III CLUSTER study which showed rapid (at Day 15) and sustained disease control with Ilaris contrast to placebo through 16 weeks, in patients with either TRAPS, HIDS/MKD or FMF.2 As a result of the positive data, the FDA granted Ilaris Breakthrough Therapy status and priority reviews for each of the three Periodic Fever Syndrome conditions.
Yum! Brands, Inc. (NYSE:YUM), jumped 1.11% and closed at $90.81 in the last trading session. The last trading range of the stock ranges between $89.84 and $91.50. During the 52-week trading session the minimum price at which share price traded, registered at $64.58 and reached to max level of $91.99. October 1 marks the starting of National Pizza Month and, as the pizza restaurant which serves and delivers more pizzas than any other pizza restaurant in the world, Pizza Hut, a partner of Yum! Brands, Inc. (YUM), is bringing pizza lovers a deal to assist them celebrate all month long.
For the month of October, customers can order two medium pizzas – any recipe and any toppings – for just $6.99 each with the purchase of two or more. October also brings Halloween which is one of Pizza Hut’s three busiest days of the year.
“Pizza is often voted the most popular food in America, so it’s only right that we devote a full month to America’s favorite food,” said said Doug Terfehr, senior director of public relations, Pizza Hut. “This October, we’re giving pizza lovers even more reason to commemorate National Pizza Month with our $6.99 Any Deal. With the unlimited topping combinations, you can honor National Pizza Month with a different flavor each day.”
There’s no doubt that pizza is America’s favorite food. In fact, 94 percent of Americans eat it at least once a month. Other fun facts about our national love affair with pizza include:
- Americans consume 100 acres of pizza per day, which is roughly 350 slices per second.
- Each person in the U.S. eats 46 pizza slices a year on average.
- About 3 billion pizzas are ordered in the U.S. per year.
- Pepperoni is the most popular pizza topping in America.
- 62 percent of Americans prefer meat toppings while 38 percent prefer vegetable toppings.